MedTrace Logo

Study to Evaluate Safety & Effectiveness of Vascular Sealant System

NCT00439309 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2017-09-07

Study results available
· View outcomes & findings →

Summary

To evaluate a new vascular sealant compared to control for the control of suture line bleeding after vascular reconstructive surgery.

Conditions

  • Peripheral Vascular Disease

Interventions

DEVICE

Gelfoam/Thrombin

Gelfoam/Thrombin

DEVICE

VascuSeal

VascuSeal

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    lead INDUSTRY

Principal Investigators

  • Vladimir I Scerbin · Confluent Surgical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00439309 on ClinicalTrials.gov